CFRX - ContraFect Corporation - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

-5.652M

Cash

14.42M

Avg Qtr Burn

-9.143M

Short % of Float

0.15%

Insider Ownership

0.65%

Institutional Own.

6.13%

Qtr Updated

06/30/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Exebacase (CF-301) (DLA) Details Prosthetic joint infection, Bacteremia	Phase 1/2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
CF-370 Details Pneumonia	Phase 1 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Exebacase (CF-301) (DLA) Details Staph aureus	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.